Sirona Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 06-12-2024
- Paid Up Capital ₹ 0.29 M
as on 06-12-2024
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.44 M
as on 06-12-2024
- Revenue 79.66%
(FY 2022)
- Profit 66.75%
(FY 2022)
- Ebitda 61.59%
(FY 2022)
- Net Worth -21.23%
(FY 2022)
- Total Assets 61.20%
(FY 2022)
About Sirona Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.29 M.
The company currently has active open charges totaling ₹4.44 M.
Kavita Paudwal, Jaydeep Palep, Saba Affendi, and One other member serve as directors at the Company.
- CIN/LLPIN
U93000MH2013PTC240249
- Company No.
240249
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Feb 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sirona Diagnostics Private Limited offer?
Sirona Diagnostics Private Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Medical Treatment Services.
Who are the key members and board of directors at Sirona Diagnostics?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saba Affendi  | Director | 30-Mar-2015 | Current |
| Niteen Tulpule | Director | 02-May-2016 | Current |
| Kavita Paudwal | Director | 07-Feb-2013 | Current |
| Jaydeep Palep | Director | 07-Feb-2013 | Current |
Financial Performance and Corporate Structure Insights of Sirona Diagnostics.
Sirona Diagnostics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 79.66% increase. The company also saw a substantial improvement in profitability, with a 66.75% increase in profit. The company's net worth observed a substantial decline by a decrease of 21.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sirona Diagnostics?
In 2021, Sirona Diagnostics had a promoter holding of 95.02% and a public holding of 4.98%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Siemens Financial Services Private Limited Creation Date: 31 Dec 2013 | ₹1.70 M | Open |
Siemens Financial Services Private Limited Creation Date: 24 Dec 2013 | ₹1.72 M | Open |
Siemens Financial Services Private Limited Creation Date: 16 Dec 2013 | ₹1.02 M | Open |
How Many Employees Work at Sirona Diagnostics?
Unlock and access historical data on people associated with Sirona Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sirona Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sirona Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
